BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1346575)

  • 1. 2-Chlorodeoxyadenosine treatment of lymphoid malignancies.
    Piro LD
    Blood; 1992 Feb; 79(4):843-5. PubMed ID: 1346575
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 3. The purine analogs--a therapeutic beauty contest.
    Cheson BD
    J Clin Oncol; 1992 Mar; 10(3):352-5. PubMed ID: 1346799
    [No Abstract]   [Full Text] [Related]  

  • 4. The purine analogs--a therapeutic beauty contest.
    Cheson BD
    J Clin Oncol; 1992 May; 10(5):868-71. PubMed ID: 1349035
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
    Cheson BD
    Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-Chlorodeoxyadenosine in the treatment of multiple myeloma.
    Dimopoulos MA; Kantarjian HM; Estey EH; Alexanian R
    Blood; 1992 Sep; 80(6):1626. PubMed ID: 1355673
    [No Abstract]   [Full Text] [Related]  

  • 7. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New analogs of deoxyadenosine for treatment of lymphoid malignancies].
    Robak T
    Przegl Lek; 1992; 49(10):355-8. PubMed ID: 1364050
    [No Abstract]   [Full Text] [Related]  

  • 10. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
    Santana VM; Mirro J; Kearns C; Schell MJ; Crom W; Blakley RL
    J Clin Oncol; 1992 Mar; 10(3):364-70. PubMed ID: 1346800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Juliusson G; Elmhorn-Rosenborg A; Liliemark J
    N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA).
    Virchis A; Mehta A
    Br J Haematol; 1998 Mar; 100(3):609. PubMed ID: 9504654
    [No Abstract]   [Full Text] [Related]  

  • 13. 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
    Saven A; Carrera CJ; Carson DA; Beutler E; Piro LD
    Blood; 1992 Aug; 80(3):587-92. PubMed ID: 1353380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
    Juliusson G; Liliemark J
    Lakartidningen; 1991 Aug; 88(35):2746-9. PubMed ID: 1680209
    [No Abstract]   [Full Text] [Related]  

  • 15. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
    Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD
    J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
    Carson DA; Piro LD; Wasson DB; Carrera CJ; Beutler E
    Adv Exp Med Biol; 1989; 253A():427-31. PubMed ID: 2576181
    [No Abstract]   [Full Text] [Related]  

  • 17. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1992 May; 267(18):2445. PubMed ID: 1349355
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphoma, hairy-cell leukemia respond to new agents.
    Oncology (Williston Park); 1992 Sep; 6(9):94. PubMed ID: 1449980
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
    Estey EH; Kurzrock R; Kantarjian HM; O'Brien SM; McCredie KB; Beran M; Koller C; Keating MJ; Hirsch-Ginsberg C; Huh YO
    Blood; 1992 Feb; 79(4):882-7. PubMed ID: 1346577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
    Carrera CJ; Yamanaka H; Piro LD; Lotz M; Carson DA
    Adv Exp Med Biol; 1989; 253B():219-25. PubMed ID: 2575348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.